M Vogt, J D Bettex, R Lüthy. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Acquired Immunodeficiency Syndrome/complicationsAcquired Immunodeficiency Syndrome/epidemiologyAcquired Immunodeficiency Syndrome/etiologyAcquired Immunodeficiency Syndrome/immunologyAcquired Immunodeficiency Syndrome/transmissionAntibodies, Viral/immunologyB-Lymphocytes/immunologyBiopterin/analogs & derivativesBiopterin/urineCandidiasis, Oral/etiologyDrug Combinations/therapeutic useHumansInterferon Type I/analysisLymphocyte ActivationNeopterinPneumonia, Pneumocystis/drug therapyPneumonia, Pneumocystis/etiologyRetroviridae/immunologyRetroviridae/pathogenicitySarcoma, Kaposi/drug therapySarcoma, Kaposi/etiologySulfamethoxazole/therapeutic useT-Lymphocytes, Regulatory/immunologyThymalfasinThymosin/analogs & derivativesThymosin/analysisTrimethoprim/therapeutic useTrimethoprim, Sulfamethoxazole Drug Combinationbeta 2-Microglobulin/analysis
Substances： See more » Antibodies, ViralDrug CombinationsInterferon Type Ibeta 2-MicroglobulinBiopterinThymosinNeopterinTrimethoprim, Sulfamethoxazole Drug CombinationTrimethoprimSulfamethoxazoleThymalfasin
Year: 1983 PMID： 6228417 DOI： 10.1055/s-2008-1069853
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN： 0012-0472 Impact factor: 0.628